167 related articles for article (PubMed ID: 37807912)
1. The application of WaterMap-guided structure-based virtual screening in novel drug discovery.
Kaczor AA; Zięba A; Matosiuk D
Expert Opin Drug Discov; 2024; 19(1):73-83. PubMed ID: 37807912
[TBL] [Abstract][Full Text] [Related]
2. Calculating Water Thermodynamics in the Binding Site of Proteins - Applications of WaterMap to Drug Discovery.
Cappel D; Sherman W; Beuming T
Curr Top Med Chem; 2017; 17(23):2586-2598. PubMed ID: 28413953
[TBL] [Abstract][Full Text] [Related]
3. Approaches to efficiently estimate solvation and explicit water energetics in ligand binding: the use of WaterMap.
Yang Y; Lightstone FC; Wong SE
Expert Opin Drug Discov; 2013 Mar; 8(3):277-87. PubMed ID: 23286874
[TBL] [Abstract][Full Text] [Related]
4. Shedding Light on Important Waters for Drug Design: Simulations versus Grid-Based Methods.
Bucher D; Stouten P; Triballeau N
J Chem Inf Model; 2018 Mar; 58(3):692-699. PubMed ID: 29489352
[TBL] [Abstract][Full Text] [Related]
5. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dynamics as a Tool for Virtual Ligand Screening.
Menchon G; Maveyraud L; Czaplicki G
Methods Mol Biol; 2024; 2714():33-83. PubMed ID: 37676592
[TBL] [Abstract][Full Text] [Related]
7. Methodologies for the Examination of Water in GPCRs.
Bortolato A; Tehan BG; Smith RT; Mason JS
Methods Mol Biol; 2018; 1705():207-232. PubMed ID: 29188565
[TBL] [Abstract][Full Text] [Related]
8. Use of machine learning approaches for novel drug discovery.
Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
[TBL] [Abstract][Full Text] [Related]
9. Understanding the challenges of protein flexibility in drug design.
Antunes DA; Devaurs D; Kavraki LE
Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
[TBL] [Abstract][Full Text] [Related]
10. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
11. Protein structure-based drug design: from docking to molecular dynamics.
Śledź P; Caflisch A
Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics as a Tool for Virtual Ligand Screening.
Menchon G; Maveyraud L; Czaplicki G
Methods Mol Biol; 2018; 1762():145-178. PubMed ID: 29594772
[TBL] [Abstract][Full Text] [Related]
13. Characterizing hydration sites in protein-ligand complexes towards the design of novel ligands.
Matter H; Güssregen S
Bioorg Med Chem Lett; 2018 Aug; 28(14):2343-2352. PubMed ID: 29880400
[TBL] [Abstract][Full Text] [Related]
14. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
[TBL] [Abstract][Full Text] [Related]
15. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
[TBL] [Abstract][Full Text] [Related]
16. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
Guimarães CR; Mathiowetz AM
J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
[TBL] [Abstract][Full Text] [Related]
17. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
Fang Y
Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
[TBL] [Abstract][Full Text] [Related]
18. The compromise of virtual screening and its impact on drug discovery.
Slater O; Kontoyianni M
Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
[No Abstract] [Full Text] [Related]
19. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
[TBL] [Abstract][Full Text] [Related]
20. Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description.
Spyrakis F; Cavasotto CN
Arch Biochem Biophys; 2015 Oct; 583():105-19. PubMed ID: 26271444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
